Management has favored organic growth, light capex, and product refreshes (Omni and OmniPro), complemented by a targeted AIO Systems partnership structured with exclusivity in North America. Stock‑based compensation is modest, and repurchases have been minimal.
We view the portfolio approach as sensible for a microcap, with discipline evident in cash generation and measured investments. Execution on the AIO build‑out is the key near‑term test.







